Literature DB >> 19408337

Adipokine signaling in inflammatory bowel disease.

A Batra1, M Zeitz, B Siegmund.   

Abstract

While the incidence of inflammatory bowel disease (IBD) is still increasing, the etiology has not finally been dissected. The main hypothesis suggests that the mucosal immune system is hyperresponsive to dietary factors and commensal bacteria in genetically predisposed individuals. Burrill Crohn himself described a local hypertrophy of the mesenteric fat tissue adjacent to the segments of inflamed intestine. In addition, more recent data indicate altered local expression and serum levels of some adipocyte-derived mediators (adipokines) with immune-modulating capacities in IBD. This review focuses on the role of adipose tissue and adipokines in the immune system, with particular focus on the mucosal immune system. The available data will serve to establish a working hypothesis on how the mesenteric fat tissue contributes to the pathogenesis of Crohn's disease.
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408337     DOI: 10.1002/ibd.20937

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

Review 1.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

2.  Serum adipokines in inflammatory bowel disease.

Authors:  Marek Waluga; Marek Hartleb; Grzegorz Boryczka; Michał Kukla; Krystyna Zwirska-Korczala
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 3.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Authors:  Siddharth Singh; Parambir S Dulai; Amir Zarrinpar; Sonia Ramamoorthy; William J Sandborn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-30       Impact factor: 46.802

Review 4.  Inflammation: a highly conserved, Janus-like phenomenon-a gastroenterologist' perspective.

Authors:  Davide Giuseppe Ribaldone; Rinaldo Pellicano; Giovanni Clemente Actis
Journal:  J Mol Med (Berl)       Date:  2018-07-09       Impact factor: 4.599

5.  Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease.

Authors:  V S Rodrigues; M Milanski; J J Fagundes; A S Torsoni; M L S Ayrizono; C E C Nunez; C B Dias; L R Meirelles; S Dalal; C S R Coy; L A Velloso; R F Leal
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

6.  A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease.

Authors:  H O Al-Hassi; D Bernardo; A U Murugananthan; E R Mann; N R English; A Jones; M A Kamm; N Arebi; A L Hart; A I F Blakemore; A J Stagg; S C Knight
Journal:  Mucosal Immunol       Date:  2012-11-21       Impact factor: 7.313

7.  Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis.

Authors:  Jennifer M Monk; Tim Y Hou; Harmony F Turk; Brad Weeks; Chaodong Wu; David N McMurray; Robert S Chapkin
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

8.  Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.

Authors:  Laurent Peyrin-Biroulet; Florent Gonzalez; Laurent Dubuquoy; Christel Rousseaux; Caroline Dubuquoy; Cécilia Decourcelle; Alain Saudemont; Mickael Tachon; Elodie Béclin; Marie-Françoise Odou; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2011-09-21       Impact factor: 23.059

9.  Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients.

Authors:  Cilene Bicca Dias; Marciane Milanski; Mariana Portovedo; Vivian Horita; Maria de Lourdes Setsuko Ayrizono; Núria Planell; Cláudio Saddy Rodrigues Coy; Lício Augusto Velloso; Luciana Rodrigues Meirelles; Raquel Franco Leal
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

Review 10.  Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat.

Authors:  Lea I Kredel; Britta Siegmund
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.